债权人如果提出要求公司清偿债务的，应根据《中华人民共和国公司法》等相 关法律法规的规定，向公司提出书面请求，并随附相关证明文件。 特此公告。 1 博士眼镜连锁股份有限公司 董事会 证券代码：300622 证券简称：博士眼镜 公告编号：2024-070 博士眼镜连锁股份有限公司 关于回购注销部分限制性股票的减资公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 博士眼镜连锁股份有限公司（以下简称"公司"）于 2024 年 7 月 5 日召开第五 届董事会第四次会议、2024 年 9 月 20 日召开 2024 年第二次临时股东大会，审议 通过了《关于调整 2021 年限制性股票与股票期权激励计划限制性股票回购价格及 回购注销部分限制性股票的议案》。鉴于限制性股票 2 名激励对象个人层面绩效考 核结果仅达到部分解除限售条件，公司回购注销上述 2 名激励对象已获授但尚未解 除限售的7,200 股限制性股票。回购注销完成后，公司注册资本相应减少7,200 元， 总股本相应减少 7,200 股。具体内容详见 2024 年 7 月 6 日公司披露于巨潮资讯网 （www. ...

政旦志远（深圳）会计师事务所（特殊普通合伙）成立日期为 2005 年 1 月 12 日，注册地址为深圳市福田区莲花街道福新社区鹏程一路 9 号广电金融中心 14F，执行事务合伙人为张建栋。更名后，原"深圳大华国际会计师事务所（特 殊普通合伙）"的各项业务、权利和义务由"政旦志远（深圳）会计师事务所（特 殊普通合伙）"承继。 因此，公司 2024 年度财务审计机构名称变更为"政旦志远（深圳）会计师 事务所（特殊普通合伙）"。本次会计师事务所变更事项仅为名称变更，不涉及 主体资格变更，不属于更换或重新聘任会计师事务所事项。 特此公告。 证券代码：300622 证券简称：博士眼镜 公告编号：2024-068 博士眼镜连锁股份有限公司 关于会计师事务所更名的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 博士眼镜连锁股份有限公司（以下简称"公司"）于 2024 年 5 月 22 日召开 了 2023 年度股东大会，审议通过了《关于拟聘任会计师事务所的议案》，同意 聘任深圳大华国际会计师事务所（特殊普通合伙）为公司 2024 年度财务审计机 构。 公司于近日收到深 ...

证券代码：300622 证券简称：博士眼镜 博士眼镜连锁股份有限公司 投资者关系活动记录表 编号：2024-010 | --- | --- | --- | --- | --- | |----------------|-------|---------------------------|-------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | □ | 特定对象调研 □ | | 分析师会议 | | 投资者关系活动 | □ | 媒体采访 □ | | 业绩说明会 | | 类别 | □ ...

Investment Rating - The report maintains a "Buy" rating for the company, with projected net profits of 140 million, 170 million, and 200 million yuan for 2024-2026, corresponding to P/E ratios of 34.3X, 28.5X, and 24.8X respectively [1] Core Views - The AR glasses market is experiencing rapid growth, with global and Chinese AR device shipments reaching 510,000 and 200,000 units in 2023, up 37.8% and 53.9% YoY respectively [1] - The company has a significant channel advantage, with a nationwide network of stores and partnerships with major AR players like Huawei, Rokid, and Thunderbird [1] - Customization capabilities in lenses are becoming a key competitive factor, with strong demand for digital, photochromic, and youth myopia control lenses [1] Industry Overview - The AR glasses market is highly concentrated, with the top 5 players accounting for 89.9% of the Chinese market in 2023 [1] - XREAL leads the global consumer AR market with an 81% share in H1 2022 [1] - The global AR device market is expected to reach 5 million units by 2027, with a CAGR of 77.0% from 2023-2027 [14] Company Strategy - The company is strengthening its position in the smart glasses sector through strategic investments and joint ventures, such as the planned collaboration with Thunderbird to develop a domestic version of Meta Ray-Ban [1] - It has established partnerships with multiple AR players, providing online prescription services and offline channel networks [1] - The company is expanding its retail network, with 515 stores nationwide as of 2023, including 495 directly operated stores [28] Financial Performance - Revenue is projected to grow from 1.176 billion yuan in 2023 to 1.771 billion yuan in 2026, with a CAGR of 14.6% [2] - Net profit attributable to shareholders is expected to increase from 128 million yuan in 2023 to 195 million yuan in 2026 [2] - The company's ROE is forecast to rise from 16.2% in 2023 to 18.5% in 2026 [2] Market Opportunities - The myopia control lens market in China is expected to exceed 30 million units by 2030, with a penetration rate of 30% and a market size of over 60 billion yuan [34] - The presbyopia lens market is driven by aging population and consumption upgrade trends, with annual demand of approximately 40 million pairs in China [36] - Emerging applications such as photochromic, night vision, and blue light blocking lenses present additional growth opportunities [42]

Investment Rating - The report maintains a "Buy" rating for the company, with projected net profits of 140 million, 170 million, and 200 million yuan for 2024-2026, corresponding to P/E ratios of 34.3X, 28.5X, and 24.8X respectively [1] Core Views - The AR glasses market is experiencing rapid growth, with global and Chinese AR device shipments reaching 510,000 and 200,000 units in 2023, up 37.8% and 53.9% YoY respectively [1] - The company has a significant channel advantage, with a nationwide network of stores and partnerships with major AR players like Huawei, Rokid, and Thunderbird [1] - Customization capabilities in lenses are becoming a key differentiator, with strong demand for digital, photochromic, and youth myopia control lenses [1] Market and Industry Analysis - The global AR device market is highly concentrated, with the top 5 players accounting for 89.9% of the Chinese market in 2023 and 55.7% globally in 2022 [1] - XREAL leads the global consumer AR market with an 81% share in H1 2022, while Thunderbird Innovation dominates the Chinese market with a 39.1% share in 2023 [1][17] - The AR industry is transitioning from B2B to B2C, with consumer sales accounting for 78.4% of the market in 2023 [1][14] Company Strategy and Positioning - The company is strengthening its position in the smart glasses sector through strategic investments and joint ventures, including a partnership with Thunderbird to develop a domestic version of Meta Ray-Ban [1] - It has established a comprehensive retail network across 23 provinces, leveraging partnerships with malls, supermarkets, and hospitals to enhance its channel capabilities [1] - The company is focusing on the integration of online and offline services, with a strong presence in both physical stores and e-commerce platforms [1] Financial Performance and Projections - Revenue is expected to grow from 1.176 billion yuan in 2023 to 1.771 billion yuan in 2026, with a CAGR of 14.6% [2] - Net profit attributable to shareholders is projected to increase from 128 million yuan in 2023 to 195 million yuan in 2026, with a CAGR of 15.1% [2] - The company's ROE is forecasted to rise from 16.2% in 2023 to 18.5% in 2026, indicating improving profitability [2] Product and Technology Trends - The AR glasses market is shifting towards lighter, more consumer-friendly designs, with magnetic/insertable myopia lenses becoming the mainstream [24] - Pre-installed prescription lenses are emerging as a key area of innovation, with companies like Apple and Meta investing heavily in this technology [24] - The company is actively participating in the development of advanced AR technologies, including partnerships for the production of customized lenses [24] Growth Opportunities - The myopia control market presents significant growth potential, with the penetration rate of defocus lenses expected to increase from 3.5% in 2021 to 30% by 2030 [33] - The aging population and rising consumer demand for premium products are driving growth in the presbyopia lens market, which currently accounts for only 1.5% of the total eyewear market [36] - Emerging applications such as photochromic, night vision, and anti-blue light lenses are creating new opportunities for companies with strong customization capabilities [42]

| --- | --- | |----------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...

证券研究报告 | 公司点评 gszqdatemark 2024 08 31 年 月 日 博士眼镜（300622.SZ） 拟与雷鸟成立合资公司，计划共同研发国产版 Meta Ray-Ban 事件：24H1 公司与雷鸟创新签订了合作框架协议，双方共同出资设立合 资公司，注册资本为 1500 万元人民币，其中公司拟使用自有资金出资 300 万元人民币，持有合资公司 20%股权，雷鸟持有 80%股权。合资公司将 计划研发拍摄眼镜、音频+AI 眼镜第一代产品，并通过授权收费形式获得 收入。在此合作项目中，公司将负责线下渠道销售和推广，参与产品研发 设计，并对产品、渠道、营销等关键策略有共同决策权，天作之合有望推 动爆品打造。 强强联合加码布局，有望复制 Meta Ray-Ban 成功路径。据新浪 VR 引 用《华尔街日报》报道，Meta 正与 Ray-Ban 制造商 EssilorLuxottica 谈判， 拟收购其 5%左右股权。根据果壳，Meta 与 Ray-Ban 合作开发的第二代 智能眼镜 Ray-Ban Meta 已售出 100 多万台，证明科技公司与强品牌&渠 道眼镜公司的合作潜力，有望共同塑造兼具功能与时 ...

证券研究报告 | 半年报点评 gszqdatemark 2024 08 31 年 月 日 博士眼镜（300622.SZ） 经营平稳，智能眼镜突破 公司发布 2024 年半年报：24H1 公司实现收入 6.01 亿元（同比+0.3%）， 归母净利润 0.52 亿元（同比-21.3%）；单 Q2 收入实现收入 3.05 亿元（同 比+5.5%），归母净利润 0.27 亿元（同比-6.6%），公司 Q2 经营稳健，智 能眼镜布局突破。 眼镜验配增速放缓，直营&加盟门店稳步扩张。24H1 公司光学眼镜及验配 服务/成镜系列产品/隐形眼镜系列产品分别实现收入 3.85/1.07/0.80 亿元 （同比-2.4%/+7.8%/+3.6%），毛利率分别为 68.4%/40.7%/32.1%（（同 比-1.0pct/-3.6pct/-5.8pct）。分渠道来看，24H1 直营/分销/电商分别实现 收入 4.67/0.47/0.87 亿元（同比-3.2%/+54.3%/+0.9%），毛利率分别为 65.3%/20.1%/39.8%。截至 24Q2 末直营门店 501 家（较年初+6 家）， 加盟门店 29 家（较年初+9 家） ...

股 票 研 究 ——博士眼镜 2024 年中报点评 Q2 业绩改善，积极推进 AI 眼镜布局 博士眼镜(300622) 批零贸易业[Table_Industry] /可选消费品 | --- | --- | --- | |----------|-------------------------------------|--------------------------| | | | | | | [table_Authors] 刘越男 ( 分析师 ) | 陈笑 ( 分析师 ) | | | 021-38677706 | 021-38677906 | | | liuyuenan@gtjas.com | chenxiao015813@gtjas.com | | 登记编号 | S0880516030003 | S0880518020002 | 本报告导读： 公司 Q2 业绩改善，彰显在复杂的消费环境中的经营韧性；战略合作雷鸟创新，积 极推进 AI 智能眼镜布局，期待收入利润进一步提振。 投资要点： [Table_Summary] 维持增持。H1 营收 6.01 亿元/+0.3%，归母净利 0.52 亿元/-21.3%， ...

证券代码：300622 证券简称：博士眼镜 博士眼镜连锁股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | --- | |----------------|-------|---------------------------------------------|-------|----------------------------------------------------------| | | ☑ | 特定对象调研 | ☑ | 分析师会议 | | 投资者关系活动 | □ | 媒体采访 □ | | 业绩说明会 | | 类别 | □ | 新闻发布会 □ | | 路演活动 | | | □ | 现场参观 | | | | | ☑ | 其他 线上会议 | | | | | | | | 华夏基金管理有限公司、西部利得基金管理有限公司、上海玖鹏 | | | | 资产管理中心(有限合伙 | ) | 、北京泓澄投资管理有限公司、上海牧 | | | | | | 鑫私募基金管理有限公司、上海喜世润投资管理有限公司、武汉 | | | | | | 美阳投资管理有限公司、上海赤钥投资公司、上海明 ...